These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9204382)

  • 41. Digitalis and digitalislike compounds down-regulate gene expression of the intracellular signaling protein 14-3-3 in rat lens.
    Lichtstein D; McGowan MH; Russell P; Carper DA
    Hypertens Res; 2000 Sep; 23 Suppl():S51-3. PubMed ID: 11016820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cardiotonic steroid bufalin-like factor in human plasma induces leukemia cell differentiation.
    Numazawa S; Honma Y; Yamamoto T; Yoshida T; Kuroiwa Y
    Leuk Res; 1995 Dec; 19(12):945-53. PubMed ID: 8632664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sodium pumps: ouabain, ion transport, and signaling in hypertension.
    Blaustein MP; Hamlyn JM; Pallone TL
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F438; author reply F439. PubMed ID: 17616574
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart.
    James PF; Grupp IL; Grupp G; Woo AL; Askew GR; Croyle ML; Walsh RA; Lingrel JB
    Mol Cell; 1999 May; 3(5):555-63. PubMed ID: 10360172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time- and dose dependent actions of cardiotonic steroids on transcriptome and intracellular content of Na
    Klimanova EA; Tverskoi AM; Koltsova SV; Sidorenko SV; Lopina OD; Tremblay J; Hamet P; Kapilevich LV; Orlov SN
    Sci Rep; 2017 Mar; 7():45403. PubMed ID: 28345607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simplified digitalis-like compounds acting on Na(+), K(+)-ATPase.
    Cerri A; Gobbini M
    J Enzyme Inhib Med Chem; 2003 Aug; 18(4):289-95. PubMed ID: 14567542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cardiotonic steroid bufalin-induced differentiation of THP-1 cells. Involvement of Na+, K(+)-ATPase inhibition in the early changes in proto-oncogene expression.
    Numazawa S; Inoue N; Nakura H; Sugiyama T; Fujino E; Shinoki M; Yoshida T; Kuroiwa Y
    Biochem Pharmacol; 1996 Jul; 52(2):321-9. PubMed ID: 8694857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Na+-K+-ATPase in rat skeletal muscle: content, isoform, and activity characteristics.
    Fowles JR; Green HJ; Ouyang J
    J Appl Physiol (1985); 2004 Jan; 96(1):316-26. PubMed ID: 12882989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Na(+), K(+)-ATPase: more than just a sodium pump.
    Scheiner-Bobis G
    Cardiovasc Res; 2011 Jan; 89(1):6-8. PubMed ID: 21097805
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of nicotine on electrogenic contribution of the Na,K-ATPase isoforms and contractile characteristics of the rat skeletal muscle].
    Kravtsova VV; Drabkina TM; Prokof'ev AV; Kubasov IV; Vasil'ev AN; Krivoĭ II
    Ross Fiziol Zh Im I M Sechenova; 2008 Oct; 94(10):1181-90. PubMed ID: 19065831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Marinobufagenin, an endogenous inhibitor of alpha-1 Na/K-ATPase, is a novel factor in pathogenesis of diabetes mellitus.
    Bagrov YY; Manusova NB; Egorova IA; Frolova EV; Fedorova OV; Bagrov AY
    Dokl Biol Sci; 2005; 404():333-7. PubMed ID: 16405108
    [No Abstract]   [Full Text] [Related]  

  • 53. 17beta-O-Aminoalkyloximes of 5beta-androstane-3beta,14beta-diol with digitalis-like activity: synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na(+),K(+)-ATPase receptor.
    Cerri A; Almirante N; Barassi P; Benicchio A; Fedrizzi G; Ferrari P; Micheletti R; Quadri L; Ragg E; Rossi R; Santagostino M; Schiavone A; Serra F; Zappavigna MP; Melloni P
    J Med Chem; 2000 Jun; 43(12):2332-49. PubMed ID: 10882359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different effects of low and high dose cardiotonic steroids on cytosolic calcium in spontaneously active hippocampal neurons and in co-cultured glia.
    Monteith GR; Blaustein MP
    Brain Res; 1998 Jun; 795(1-2):325-40. PubMed ID: 9622665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
    Ottlecz A; Bensaoula T
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ouabain sensitivity and expression of Na/K-ATPase alpha- and beta-subunit isoform genes during bovine early development.
    Betts DH; MacPhee DJ; Kidder GM; Watson AJ
    Mol Reprod Dev; 1997 Feb; 46(2):114-26. PubMed ID: 9021743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats.
    Pamnani MB; Chen S; Yuan CM; Haddy FJ
    Hypertension; 1994 Jan; 23(1 Suppl):I106-9. PubMed ID: 8282340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of rat Na+/K+-ATPase isoforms by endogenous digitalis extracts from neonatal human plasma.
    Crambert G; Balzan S; Paci A; Decollogne S; Montali U; Ghione S; Lelièvre LG
    Clin Exp Hypertens; 1998; 20(5-6):669-74. PubMed ID: 9682922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-dependent effect of ouabain on renal Na+,K+-ATPase.
    Silva E; Serrão MP; Soares-da-Silva P
    Life Sci; 2011 Apr; 88(15-16):719-24. PubMed ID: 21338612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Inhibitory action of peruvoside and neriifolin on Na+, K(+)-ATPase].
    Ye YX; Yang XR
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):491-4. PubMed ID: 1966653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.